Treatment of Advanced Gastric Cancer: Where We Are in 2003

Publisher： Karger

E-ISSN： 2296-5262|26|3|214-215

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.3, 2003-07, pp. : 214-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Home parenteral nutrition in advanced cancer: where are we?

By Mackenzie Michelle L.   Gramlich Leah  

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 1, 2008-01 ,pp. : 1-11

NRC Research Press

Access to resources Recommend Favorite

Targeted HER2 Treatment in Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-02 ,pp. : 26-33

Karger

Access to resources Recommend Favorite

Treatment of Advanced Gastric Cancer with Oral Idarubicin, Leucovorin, and Tegafur

By  

Oncology Research and Treatment, Vol. 22, Iss. 4, 1999-09 ,pp. : 292-294

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

By  

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 255-258

Karger

Access to resources Recommend Favorite

Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 235-247

John Wiley & Sons Inc

Access to resources Recommend Favorite